✦ LIBER ✦

MP-08.23: Zoledronic acid produces benefits in patients with early malignant bone disease from hormone-refractory prostate cancer

✍ Scribed by F. Saad; Y.M. Chen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-08.24: Zoledronic acid-mediated norma

✍ F. Saad; A. Lipton; R. Coleman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Combined use of zoledronic acid and 153S

✍ Marnix G. E. H. Lam; Amel Dahmane; Wil H. M. Stevens; Peter P. van Rijk; John M. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB

Re: Economic Evaluation of Denosumab Com

✍ Hans-Peter Schmid; Robert Theiler 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 587 KB

The risk of renal impairment in hormone-

✍ William K. Oh; Kevin Proctor; Mari Nakabayashi; Carolyn Evan; Lauren K. Tormey; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

MP-08.12: One single dose of zoledronic

✍ A. Lekas; M. Chrisofos; I. Fokitis; A. Balangas; A. Kollias; C. Deliveliotis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 87 KB

810 ORAL Risk and risk factors of renal

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 429 KB